Status:
RECRUITING
A Study to Assess the Safety and Efficacy of IPN10200 in Adult Participants With Upper Limb Spasticity.
Lead Sponsor:
Ipsen
Conditions:
Spasticity
Eligibility:
All Genders
18-70 years
Phase:
PHASE1
PHASE2
Brief Summary
The purpose of the study is to assess the safety and efficacy of increasing doses of IPN10200 with the aim to evaluate the Pharmacodynamics (PD) profile of IPN10200 and to establish the total IPN10200...
Eligibility Criteria
No eligibility criteria provided.
Key Trial Info
Start Date :
April 29 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 30 2027
Estimated Enrollment :
240 Patients enrolled
Trial Details
Trial ID
NCT04752774
Start Date
April 29 2021
End Date
October 30 2027
Last Update
February 24 2026
Active Locations (80)
Enter a location and click search to find clinical trials sorted by distance.
1
Rancho Los Amigos National Rehab
Downey, California, United States, 90242
2
Kansas Institute of Research
Overland Park, Kansas, United States, 66211
3
Quest Research Institute
Farmington Hills, Michigan, United States, 48334
4
Einstein Physical Medicine and Rehabilitation at Elkins Park
Elkins Park, Pennsylvania, United States, 19027